Mitral Valve Disease  /  Cost of Disease

7 Matching Facts

Search matching Facts:
No results to display
    • Pulmonary hypertension is a complication in at least 23% of patients with significant mitral regurgitation due to flail leaflet, and approximately doubles the risk of death and heart failure after diagnosis.
       
    • Mitral regurgitation patients who did not undergo surgery saw an increased use of medical therapies from 12% to 47% over 4.5 years.
       
    • Hospital Discharges from Heart Valve Disease in 2010*
       
    • Mitral valve disease is present in 5.1% of the population ages 65 and older.
       
    • Patients with severe MR who don’t have surgery have mortality rates of 20% after 1-year and 50% after 5-years
       
    • Mitral valve disease costs
      Mitral valve disease (symptomatic and asymptomatic) costs the U.S. at least $13.2 billion in direct healthcare expenditures each year.